Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-06
2007-02-06
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S488000, C514S425000, C514S417000, C548S478000, C548S547000, C560S016000
Reexamination Certificate
active
10839111
ABSTRACT:
Optically active 3-amino-butene and 1,2-dihydroxy-3-amino-butane intermediate compounds, useful in the synthesis of HIV-protease inhibitors and methods of preparing these intermediate compounds are disclosed.
REFERENCES:
patent: 5484926 (1996-01-01), Dressman et al.
patent: 5587481 (1996-12-01), Allen et al.
patent: 5705647 (1998-01-01), Babu et al.
patent: 0 984 000 (2000-03-01), None
patent: WO 93/07142 (1993-04-01), None
patent: WO 97/11937 (1997-04-01), None
patent: WO 97/11938 (1997-04-01), None
patent: WO 2004099129 (2004-11-01), None
Kano, et al. J. Org. Chem., vol. 54(3), 513-515 (1989).
White, et al., Chemical Communications, (16), pp. 2012-2013 (2003).
Dobson, et al., Tetrahedron Letters, 40, pp. 3119-3122 (1999).
Lewanowicz et al., Advanced Materials for Optics and Electronics, vol. 6, pp. 225-232 (1996).
Leallyn B. Clapp, J. Am. Chem. Soc., 73, pp. 2584-2586 (1951).
Clapp, et al., J. Am. Chem. Soc., 73, pp. 2121-2124 (1951).
Kano, et al., J. Amer. Chem. Soc., 54(3) pp. 513-515 (1989).
Annedi, et al., J. Org. Chem., 68, pp. 1043-1049 (2003).
Elall, E., et al., “Synthesis Of Thizolidinones From 1,4-Dithiocyanatobut-2-enes And Their Use As Masked 2-Amino-1-Mercaptobut-3-enes,”J. Chem. Soc. Perkin Trans. 1, 1987, 2729-2736.
Huber, S., et al., “1,3-Butadienyl Thiocyanate In The Diels-Alder Reaction Followed by a [3,3]- Signatropic Shift,”Helvetica Chimica Acta, 1986, 1898-1915, vol. 69.
Inaba, T., et al., “(1S)-1-[(4R)-2,2-Dimethyl-1,3-dioxolan-4-yl]-2-hydroxyethylammoniun Benzoate, A Versatile Building Block For Chiral 2-Aminoalkanols: Concise synthesis And Application To Nelfinavir, A Potent HIV-Protease Inhibitor,”J. Org. Chem., 2000, 1623-1628, No. 65.
Kano, s., et al., “Effect of Polar Solvents On The Rates Of Claisen Rearrangements: Assessment Of Ionic Character,”The Journal Of Organic Chemistry, 1989, 515-516, vol. 54.
Lavielle, S., et al., “A Total Slynthesis Of Biotin Based On The Stereoselective Alkylation Of Sulfoxides,”Journal Of The American Chemical Society, 1978, 1558-1563, vol. 100, No. 5.
Rieger, D., et al., “A Concise Formal Synthesis Of The Potent HIV Protease Inhibitor Nelfinavir Mesylate,”J. Org. Chem., 1997, 8546-8548, vol. 62.
White, J., et al., “Total Synthesis Of (+)-Kalkitoxin,”Chem. Comm., 2003, 2012-2013, No. 16.
Kano, S., et al., “New Diastereoselective Synthesis Of Oxazolidin-2-ones Through Carbon-Carbon Bond Formation On Cyclic Carbamoyloxy Radicals,”The Journal Of OrganicChemistry, 1989, 513-516, vol. 54, No. 3.
Reetz, et al., “Asymmetric Dihydroxylation of Chiral γ-Amino α, β-Unsaturated Esters: Turning the Mismatched into the Matched Case via Protective Group Tuning,”Tetrahedron Letters, 1996, 9293-9296, vol. 37, No. 52.
Albizati Kim Francis
Babu Srinivasan
Agouron Pharmaceuticals , Inc.
Grazier Nyeemah
Hutchinson Keith D.
McKane Joseph K.
Zielinski Bryan C.
LandOfFree
Intermediates useful in the synthesis of HIV-protease... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intermediates useful in the synthesis of HIV-protease..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intermediates useful in the synthesis of HIV-protease... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3888497